KMT2A and acute myeloid leukemia: Notably, FOXM1 inhibition by either Siomycin A or FOXM1-specific peptide significantly inhibited colony-forming ability and induced apoptosis of MA9.3 cells, MA9.3RAS and primary CD34+ cells from MLL-r AML patients but not normal CD34+ cells (Fig. 8a–d).